3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Congenital Abnormalities
2
Carcinoma, Renal Cell
2
Uveal Melanoma
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Retinoblastoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Osteosarcoma
1
Optic Nerve Glioma
1
Oligodendroglioma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neuroectodermal Tumors, Primitive
1
Neuroblastoma
1
Neoplasms, Neuroepithelial
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Medulloblastoma
1
Lung Neoplasms
1
Liver Neoplasms
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Erythroblastic, Acute
1
Interventions
fludarabine phosphate
10
Cyclophosphamide
8
Busulfan
8
Whole-Body Irradiation
7
Peripheral Blood Stem Cell Transplantation
7
Mycophenolic Acid
7
Antilymphocyte Serum
7
Tacrolimus
6
Methotrexate
5
Cyclosporine
5
thymoglobulin
4
Melphalan
4
Rituximab
3
Radiotherapy
3
Etoposide
3
Cord Blood Stem Cell Transplantation
3
Sirolimus
2
Ondansetron
2
Granulocyte Colony-Stimulating Factor
2
Dexamethasone
2
Cytarabine
2
Carmustine
2
Calcium Dobesilate
2
Aprepitant
2
ruxolitinib
1
fludarabine
1
fedratinib
1
etoposide phosphate
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Neutrophilic, Chronic
×
Immunologic Techniques
×
Clear all
No trials found.